These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33478477)

  • 21. Disease-specific Pay-for-Performance Programs: Do the P4P Effects Differ Between Diabetic Patients With and Without Multiple Chronic Conditions?
    Huang YC; Lee MC; Chou YJ; Huang N
    Med Care; 2016 Nov; 54(11):977-983. PubMed ID: 27547944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effectiveness of a pay for performance program on diabetes care in Taiwan: A nationwide population-based longitudinal study.
    Lin TY; Chen CY; Huang YT; Ting MK; Huang JC; Hsu KH
    Health Policy; 2016 Nov; 120(11):1313-1321. PubMed ID: 27780591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the relationship between a chronic disease care management program and california pay-for-performance diabetes care cholesterol measures in one medical group.
    Cutler TW; Palmieri J; Khalsa M; Stebbins M
    J Manag Care Pharm; 2007 Sep; 13(7):578-88. PubMed ID: 17874864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage.
    Liao PJ; Lin TY; Wang TC; Ting MK; Wu IW; Huang HT; Wang FC; Chang HC; Hsu KH
    Medicine (Baltimore); 2016 Apr; 95(14):e3282. PubMed ID: 27057892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pay-for-performance for shared care of diabetes in Taiwan.
    Lee IT; Hsu CC; Sheu WH; Su SL; Wu YL; Lin SY
    J Formos Med Assoc; 2019 Nov; 118 Suppl 2():S122-S129. PubMed ID: 31471222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of individual and neighborhood social risks on diabetes pay-for-performance program under a single-payer health system.
    Tsai WC; Huang KH; Chen PC; Chang YC; Chen MS; Lee CB
    Soc Sci Med; 2023 Jun; 326():115930. PubMed ID: 37146356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergy between the pay-for-performance scheme and better physician-patient relationship might reduce the risk of retinopathy in patients with type 2 diabetes.
    Chiou SJ; Liao K; Huang YT; Lin W; Hsieh CJ
    J Diabetes Investig; 2021 May; 12(5):819-827. PubMed ID: 33025682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does pay-for-performance benefit patients with multiple chronic conditions? Evidence from a universal coverage health care system.
    Chen CC; Cheng SH
    Health Policy Plan; 2016 Feb; 31(1):83-90. PubMed ID: 25944704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing Taiwan's pay-for-performance program for diabetes care: a cost-benefit net value approach.
    Lu JR; Chen YI; Eggleston K; Chen CH; Chen B
    Eur J Health Econ; 2023 Jul; 24(5):717-733. PubMed ID: 35995886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The unintended consequence of diabetes mellitus pay-for-performance (P4P) program in Taiwan: are patients with more comorbidities or more severe conditions likely to be excluded from the P4P program?
    Chen TT; Chung KP; Lin IC; Lai MS
    Health Serv Res; 2011 Feb; 46(1 Pt 1):47-60. PubMed ID: 20880044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of diabetes pay-for-performance incentive designs.
    Hsieh HM; Tsai SL; Shin SJ; Mau LW; Chiu HC
    Med Care; 2015 Feb; 53(2):106-15. PubMed ID: 25397966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan.
    Sheu SJ; Lin WL; Kao Yang YH; Hwu CM; Cheng CL
    BMC Health Serv Res; 2018 Aug; 18(1):638. PubMed ID: 30111370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient and provider factors associated with enrolment in the pre-end-stage renal disease pay-for-performance programme in Taiwan: a cross-sectional study.
    Hu HY; Jian FX; Lai YJ; Yen YF; Huang N; Hwang SJ
    BMJ Open; 2019 Sep; 9(9):e031354. PubMed ID: 31519682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of national pre-ESRD care program on expenditures and mortality in incident dialysis patients: A population-based study.
    Lin MY; Cheng LJ; Chiu YW; Hsieh HM; Wu PH; Lin YT; Wang SL; Jian FX; Hsu CC; Yang SA; Lee HL; Hwang SJ
    PLoS One; 2018; 13(6):e0198387. PubMed ID: 29856821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects and Factors Related to Adherence to A Diabetes Pay-for-Performance Program: Analyses of a National Health Insurance Claims Database.
    Chi MJ; Chou KR; Pei D; Hwang JS; Quinn L; Chung MH; Liao YM
    J Am Med Dir Assoc; 2016 Jul; 17(7):613-9. PubMed ID: 27073041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Changes in Diabetes Pay-for-Performance Incentive Designs on Patient Risk Selection.
    Hsieh HM; Tsai SL; Mau LW; Chiu HC
    Health Serv Res; 2016 Apr; 51(2):667-86. PubMed ID: 26152649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Educational attainment affects the diagnostic time in type 2 diabetes mellitus and the mortality risk of those enrolled in the diabetes pay-for-performance program.
    Liao YS; Tsai WC; Chiu LT; Kung PT
    Health Policy; 2023 Dec; 138():104917. PubMed ID: 37776765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of a PPO pay-for-performance program on patients with diabetes.
    Chen JY; Tian H; Taira Juarez D; Hodges KA; Brand JC; Chung RS; Legorreta AP
    Am J Manag Care; 2010 Jan; 16(1):e11-9. PubMed ID: 20059287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient assessment of diabetes care in a pay-for-performance program.
    Chiu HC; Hsieh HM; Lin YC; Kuo SJ; Kao HY; Yeh SC; Chang WH; Hsiao PJ; Chen YS; Lin SL; Lo GH; Ker CG; Hung YH; Cheng HA; Chou TH; Chou SY; Wang JH; Wang CF
    Int J Qual Health Care; 2016 Apr; 28(2):183-90. PubMed ID: 26819445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-Effectiveness of a Diabetes Pay-For-Performance Program in Diabetes Patients with Multiple Chronic Conditions.
    Hsieh HM; Gu SM; Shin SJ; Kao HY; Lin YC; Chiu HC
    PLoS One; 2015; 10(7):e0133163. PubMed ID: 26173086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.